Of particular interest was the concomitant upregulation of the dual specificity phosphatases 4 and 6 (DUSP4 and 6), whose inactivation has recently emerged as digenic synthetic lethal targets in NRAS and BRAF mutant melanoma cell lines acting through ERK hyperactivation [20]. The gene discussed is BRAF; the disease is melanoma.